<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02529670</url>
  </required_header>
  <id_info>
    <org_study_id>53123716.3.0000.5511</org_study_id>
    <nct_id>NCT02529670</nct_id>
  </id_info>
  <brief_title>Low Level Laser Therapy in the Dorsal Root Ganglion in the Treatment of Chronic Low Back Pain</brief_title>
  <official_title>Study of the Effect of Low Level Laser Therapy in the Dorsal Root Ganglion in the Diagnosis and Treatment of Chronic Low Back Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nove de Julho</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Nove de Julho</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic axial low back pain is a public health problem and has a high socioeconomic impact.
      The dorsal ganglion of the second spinal nerve (GDL2) is a cluster of neuronal bodies
      responsible for sensory afferent inputs from more than 80% of the lumbar region. Low-level
      laser therapy (LLLT) is proven effective to help relieve pain. Thus, the aim of this project
      is to determine the effect of LLLT on GDL2 when applied to assist in the diagnosis and
      treatment of chronic axial low back pain. Methodology: 45 patients will be randomized into
      three groups: laser, radiofrequency and local anesthetic. The patient will be positioned in a
      prone horizontal position under anesthetic monitoring. The intervertebral foramen between the
      second and third lumbar vertebrae will be accessed by percutaneous puncture guided by
      fluoroscopy. In the local anesthetic group, injection of 1 ml lidocaine without
      vasoconstrictor will be applied in the tubes G20, 150 mm long and 5 mm active tip in contact
      with the target. In the radiofrequency group, neuromodulation will be held for 300 seconds at
      42oC. In the laser group, the laser Photon III® (DCM) will be applied through optic fiber
      crossing G18 cannulas, during 84 seconds. The pain score will be assessed by visual analog
      scale. Temperature will be measured and aspirate periganglionic sample, trans-operatively, to
      study Interleucins-1β and TNF-alpha assessed by ELISA and genetic evaluation trough RNA seek,
      RNA isolation and ATP quantification. The data will be evaluated for normality and subjected
      to appropriate statistical analysis, in order to seek representation, as same as the level of
      significance of the studied samples.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">November 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Intensity Measure using Visual Analog Scale</measure>
    <time_frame>5 minutes before procedure</time_frame>
    <description>Self reported pain intensity following Visual Analog Scale, scored 0-10 (0=no pain; 10=the worst pain ever).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Intensity Measure using the change in Visual Analog Scale from baseline at 1 month</measure>
    <time_frame>5 minutes after procedure</time_frame>
    <description>Patients will report the intensity of the pain using the score in visual analogue scale, scored 0-10 (0=no pain; 10=the worst pain ever).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Intensity Measure using the Visual Analog Scale</measure>
    <time_frame>1 month and 6 months after procedure</time_frame>
    <description>In follow up, patients will report the intensity of the pain using the score in visual analogue scale, scored 0-10 (0=no pain; 10=the worst pain ever).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Immunochemistry to analyse IL-1, IL-10, TNF alfa.</measure>
    <time_frame>Samples collected 1 minute after the application of laser, radiofrequency or lidocaine</time_frame>
    <description>Through the needle used the sample will be collected and examined by immunocytochemical staining and ELISA.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">31</enrollment>
  <condition>Pain</condition>
  <condition>Low Back Pain</condition>
  <condition>Nociceptive Pain</condition>
  <condition>Neuropathic Pain</condition>
  <condition>Low Level Laser Therapy</condition>
  <arm_group>
    <arm_group_label>Laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15 patients will be positioned in a prone horizontal position under anesthetic monitoring. The intervertebral foramen between the second and third lumbar vertebrae will be accessed by percutaneous puncture guided by fluoroscopy. Laser Photon III® (DCM) will be applied through fiber optics crossing G18 cannulas, during 84 seconds.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Radiofrequency</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>15 patients will receive radiofrequency in the second dorsal root ganglion through tubes G20, 150 mm long and 5 mm active tip in contact with the target, neuromodulation will be held for 300 seconds at 42oC.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Drug: Lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In the local anesthetic group, 15 patients will receive the injection of 1 ml lidocaine without vasoconstrictor will be applied in the tubes G18, 150 mm long to block the second dorsal root ganglion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laser</intervention_name>
    <description>Low level laser therapy will be delivered through Laser Photon III ® (DMC) in the second lumbar dorsal root ganglion.</description>
    <arm_group_label>Laser</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Drug: Lidocaine</intervention_name>
    <description>1 mL of Lidocaine will be delivered in the second lumbar dorsal root ganglion through fluoroscopy.</description>
    <arm_group_label>Drug: Lidocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radiofrequency</intervention_name>
    <description>Radiofrequency will be delivered during 300 seconds, 42oC in the second lumbar dorsal root ganglion.</description>
    <arm_group_label>Radiofrequency</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic low back pain (more than 3 months of nociceptive or neuropathic pain).

          -  No neurological deficits

        Exclusion Criteria:

          -  Active lumbar cancer

          -  Active infection

          -  Coagulation disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Vanessa M Holanda, MD, MS</last_name>
    <phone>11964430345</phone>
    <email>vanessamila@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Nove de Julho Universtiy</name>
      <address>
        <city>Sao Paulo</city>
        <state>São Paulo</state>
        <zip>01321001</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vanessa M Holanda, MD, MS</last_name>
      <phone>+5511964430345</phone>
      <email>vanessamila@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Benedito Pereira, MD, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vanessa M Holanda, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean G de Oliveira, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniela Silva, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carlos Vanderlei M de Holanda, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bartolomeu Quidute, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miguel Ontaneda, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Cristina Chavantes, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cicero Diego S Cabral, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>José Oswaldo de Oliveira Júnior, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Rydevik BL, Myers RR, Powell HC. Pressure increase in the dorsal root ganglion following mechanical compression. Closed compartment syndrome in nerve roots. Spine (Phila Pa 1976). 1989 Jun;14(6):574-6.</citation>
    <PMID>2749371</PMID>
  </reference>
  <reference>
    <citation>Hart LG, Deyo RA, Cherkin DC. Physician office visits for low back pain. Frequency, clinical evaluation, and treatment patterns from a U.S. national survey. Spine (Phila Pa 1976). 1995 Jan 1;20(1):11-9.</citation>
    <PMID>7709270</PMID>
  </reference>
  <reference>
    <citation>Deyo RA, Mirza SK, Martin BI. Back pain prevalence and visit rates: estimates from U.S. national surveys, 2002. Spine (Phila Pa 1976). 2006 Nov 1;31(23):2724-7.</citation>
    <PMID>17077742</PMID>
  </reference>
  <reference>
    <citation>Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006 May;10(4):287-333. Epub 2005 Aug 10.</citation>
    <PMID>16095934</PMID>
  </reference>
  <reference>
    <citation>Frymoyer JW, Cats-Baril WL. An overview of the incidences and costs of low back pain. Orthop Clin North Am. 1991 Apr;22(2):263-71. Review.</citation>
    <PMID>1826550</PMID>
  </reference>
  <reference>
    <citation>Katz JA. Getting the lowdown on back pain. Nursing. 2001 Dec;31(12):24.</citation>
    <PMID>11921711</PMID>
  </reference>
  <reference>
    <citation>Schaeffer V, Meyer L, Patte-Mensah C, Mensah-Nyagan AG. Progress in dorsal root ganglion neurosteroidogenic activity: basic evidence and pathophysiological correlation. Prog Neurobiol. 2010 Sep;92(1):33-41. doi: 10.1016/j.pneurobio.2010.04.009. Epub 2010 May 10. Review.</citation>
    <PMID>20438798</PMID>
  </reference>
  <reference>
    <citation>de Souza Grava AL, Ferrari LF, Defino HL. Cytokine inhibition and time-related influence of inflammatory stimuli on the hyperalgesia induced by the nucleus pulposus. Eur Spine J. 2012 Mar;21(3):537-45. doi: 10.1007/s00586-011-2027-8. Epub 2011 Sep 25.</citation>
    <PMID>21947908</PMID>
  </reference>
  <reference>
    <citation>Chow R, Yan W, Armati P. Electrophysiological effects of single point transcutaneous 650 and 808 nm laser irradiation of rat sciatic nerve: a study of relevance for low-level laser therapy and laser acupuncture. Photomed Laser Surg. 2012 Sep;30(9):530-5. doi: 10.1089/pho.2012.3248. Epub 2012 Jul 10.</citation>
    <PMID>22779441</PMID>
  </reference>
  <reference>
    <citation>Lauria G, Bakkers M, Schmitz C, Lombardi R, Penza P, Devigili G, Smith AG, Hsieh ST, Mellgren SI, Umapathi T, Ziegler D, Faber CG, Merkies IS. Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J Peripher Nerv Syst. 2010 Sep;15(3):202-7. doi: 10.1111/j.1529-8027.2010.00271.x.</citation>
    <PMID>21040142</PMID>
  </reference>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 11, 2015</study_first_submitted>
  <study_first_submitted_qc>August 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 20, 2015</study_first_posted>
  <last_update_submitted>March 14, 2016</last_update_submitted>
  <last_update_submitted_qc>March 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 16, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Nove de Julho</investigator_affiliation>
    <investigator_full_name>Vanessa Milanesi Holanda</investigator_full_name>
    <investigator_title>MD, MS</investigator_title>
  </responsible_party>
  <keyword>Low Level Laser Therapy</keyword>
  <keyword>Low Back Pain</keyword>
  <keyword>Diagnosis</keyword>
  <keyword>Genetic</keyword>
  <keyword>Clinical trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
    <mesh_term>Neuralgia</mesh_term>
    <mesh_term>Nociceptive Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

